Close Menu

NEW YORK – Dutch diagnostics company SkylineDx announced on Tuesday a partnership with the multiple myeloma department of Wuerzburg University Medical Center II in Germany to assess the company's MMprofiler diagnostic test.

The MMprofiler test is a microarray-based, gene-expression test for multiple myeloma based on a 92-gene signature called SKY92 for diagnosing patients in high and standard risk groups.  The test runs on Thermo Fisher Scientific Affymetrix microarrays and is offered as a CE-IVD kit in Europe, and as a laboratory-developed test in the US.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.